Amy L Cole Selected Research

theta-defensin

4/2009	Reawakening retrocyclins: ancestral human defensins active against HIV-1.
12/2007	Retrocyclin RC-101 overcomes cationic mutations on the heptad repeat 2 region of HIV-1 gp41.
5/2007	The retrocyclin analogue RC-101 prevents human immunodeficiency virus type 1 infection of a model human cervicovaginal tissue construct.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Amy L Cole Research Topics

Disease

10	Infections 01/2020 - 02/2007
6	HIV Infections (HIV Infection) 01/2020 - 01/2012
2	Bacterial Vaginosis 01/2020 - 01/2015
2	Virus Diseases (Viral Diseases) 04/2015 - 04/2009
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 07/2011
1	Atherosclerosis 08/2003
1	Inflammation (Inflammations) 08/2003

Drug/Important Bio-Agent (IBA)

3	theta-defensinIBA 04/2009 - 05/2007
3	Anti-Infective Agents (Microbicides)IBA 12/2007 - 02/2007
2	Peptides (Polypeptides)IBA 01/2017 - 01/2012
2	Amyloid (Amyloid Fibrils)IBA 04/2015 - 01/2011
2	Proteins (Proteins, Gene)FDA Link 01/2015 - 01/2015
2	Antiviral Agents (Antivirals)IBA 01/2015 - 10/2009
2	RC 101IBA 12/2007 - 05/2007
1	Matrix Metalloproteinases (MMPs)IBA 01/2020
1	3-hydroxyflavoneIBA 01/2016
1	Chalcone (Benzalacetophenone)IBA 01/2016
1	Sodium Bicarbonate (Baking Soda)FDA LinkGeneric 04/2015
1	BuffersIBA 04/2015
1	Phosphates (Orthophosphate)IBA 04/2015
1	Complex MixturesIBA 01/2015
1	matriptaseIBA 07/2014
1	Local Anti-Infective Agents (Antiseptics)IBA 07/2011
1	prostatic acid phosphataseIBA 01/2011
1	LuciferasesIBA 10/2009
1	beta-DefensinsIBA 04/2009
1	AminoglycosidesIBA 04/2009
1	glycoprotein 41IBA 12/2007
1	LectinsIBA 12/2007
1	oxidized- L- alpha- 1- palmitoyl- 2- arachidonoyl- sn- glycero- 3- phosphorylcholineIBA 08/2003
1	Fibronectins (Fibronectin)IBA 08/2003

Therapy/Procedure

1	Therapeutics 01/2020